Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Ave cost of a crystalloid-based volume replacement regimen lower than of acolloid-based volume replacement strategy?
Autore:
Boldt, J; Suttner, S; Huttner, I; Kumle, B; Piper, S; Krumholz, W;
Indirizzi:
Klinikum Stadt Ludwigshafen, Abt Anasthesiol & Intensivmed, D-67063 Ludwigshafen, Germany Klinikum Stadt Ludwigshafen Ludwigshafen Germany D-67063 shafen, Germany Bethlehem Krankenhaus, Abt Anasthesiol, Stolberg, Germany Bethlehem Krankenhaus Stolberg Germany t Anasthesiol, Stolberg, Germany
Titolo Testata:
INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
fascicolo: 3, volume: 28, anno: 2001,
pagine: 144 - 149
SICI:
1424-5485(200105)28:3<144:ACOACV>2.0.ZU;2-R
Fonte:
ISI
Lingua:
ENG
Soggetto:
HYDROXYETHYL STARCH; THERAPY; ALBUMIN;
Keywords:
abdominal surgery; cost; volume replacement; gelatin; hydroxyethyl starch; crystalloids;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
24
Recensione:
Indirizzi per estratti:
Indirizzo: Boldt, J Klinikum Stadt Ludwigshafen, Abt Anasthesiol & Intensivmed, Bremserstr 79,D-67063 Ludwigshafen, Germany Klinikum Stadt Ludwigshafen Bremserstr 79 Ludwigshafen Germany D-67063
Citazione:
J. Boldt et al., "Ave cost of a crystalloid-based volume replacement regimen lower than of acolloid-based volume replacement strategy?", INFUS THER, 28(3), 2001, pp. 144-149

Abstract

Objective: Adequate volume therapy is a cornerstone for treating patients undergoing major surgery. The age-old crystalloid/colloid debate is still unsolved. The current push to reduce cost may also include considerations about the lowest cost for volume replacement therapy. Material and Methods: The study was designed as a prospective, randomized, single-institutional, clinical investigation in an urban, university-affiliate hospital. 100 patients scheduled for major abdominal surgery were randomized into 4 groups: either crystalloids (Ringer's lactate (RL), n = 25), 6% hydroxyethyl starch (mean molecular weight (MW) 200 kDa, degree of substitution (DS) 0.5; HES 200, n = 25), a new 6% hydroxyethyl starch (MW 130 kDa, DS 0.4; HES 130, n = 25), or 4% modified fluid gelatin (MW 35 kDa, n = 25) were given until the Ist postoperative day (POD) to keep central venous pressure between 8 and 12 mm Hg. Cost for either volume replacement regimen were calculated, including acquisition cost of the substance as well as those of blood products and disposables used. Results: Even when infusing high doses of crystalloids (until Ist POD: 11,550 +/- 850 ml), 10 patients showed orthostatic dysregulation. Gelatin-treated patients needed the largest amount of volume (3,350 /- 360 ml) of the colloid groups (HES 200: 2,350 +/- 240 ml; HES 130: 2,590 +/- 310 ml). Cost of blood products exceeded cost of non-blood fluids markedly (RL group: EUR 68.60 per patient), but did not differ between the four groups. Difference of total cost (fluids, blood products, disposables) between the crystalloid and the cheapest colloid group (HES 200) was EUR 12.60 per patient. Conclusion: By the choice of a particular volume replacementstrategy, no big cost savings can be achieved in patients undergoing majorabdominal surgery. Other aspects than only acquisition cost should be taken into consideration when deciding for a specific volume replacement strategy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/07/20 alle ore 14:47:14